Terminated PHASE3 INTERVENTIONAL 1-arm NCT01029444

Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes

Effects of Pulsatile Intravenous Insulin on Brittle Diabetes and Glucose Control

Sponsor: Advanced Diabetes Treatment Centers

Interventions Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog )

Updated 5 times since 2017 Last updated: Feb 2, 2016 Started: Mar 31, 2007 Primary completion: Mar 31, 2011 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Administrative

Other terminated trials from Advanced Diabetes Treatment Centers

More terminations from Advanced Diabetes Treatment Centers

Other Diabetes Mellitus trials with similar outcome

Browse all Diabetes Mellitus trials

This PHASE3 trial investigates Diabetes Mellitus and is currently terminated or withdrawn. Advanced Diabetes Treatment Centers leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Advanced Diabetes Treatment Centers
Florida Atlantic University

Data source: Florida Atlantic University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boca Raton, United States